Symposium 2019

The 2019 GARROD Symposium will be held from May 9 – 11, 2019 at The Sheraton Centre.

If you wish to get on a mailing list to receive updates for this symposium, please contact

Registration and Brochure are available – links below

Location and Accommodation

The Sheraton Centre, Toronto, ON

123 Queen Street West

Toronto, Ontario M5H 2M9

Details on rooms blocks and rates can be found here.

Satellite Symposiums

Please see details and information below.

Horizon Therapeutics Canada – May 9, 9:30-11:30 AM – UCD Diagnosis, Management & Treatment

*Breakfast will be provided

Presenter: Dr. Barbara Burton

Professor of Pediatrics at the Northwestern University Feinberg School of Medicine,

Clinical Practice Director; Division of Genetics, Birth Defects and Metabolism at the Ann & Robert H. Lurie Children’s Hospital of Chicago


  1. Discuss current diagnosis, management & treatment of Urea Cycle Disorders

  2. Understand the risks associated with high ammonia levels

  3. Provide the latest clinical data for RAVICTI® (glycerol phenylbutyrate) Oral Liquid

  4. Discussion & Feedback Session

You can view the Save the Date poster here.

Please register for the Symposia here – click on link below:

Recordati Rare Diseases Canada – May 9, 2:00-3:30 PM –

Management of propionic, methylmalonic and isovaleric acidurias in Canada

  1. Saadet Andrews (30 minutes): Canadian Metabolic Physician practices in the acute and chronic management of PA, MMA and IVA

  2. Chitra Prasad (30 minutes): International treatment guidelines for PA, MMA and IVA

  3. Discussion (30 minutes)


  1. Recognize the phenotypes of PA, MMA and IVA in Canada

  2. Summarize Canadian physician practices for the management of PA, MMA and IVA

  3. Review international treatment guidelines of PA, MMA and IVA